×
About 214 results

ALLMedicine™ Prostate Cancer Staging Center

Research & Reviews  89 results

Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate ...
https://doi.org/10.1111/1754-9485.13162
Journal of Medical Imaging and Radiation Oncology; Papa N, Perera M et. al.

Mar 5th, 2021 - There has been a growing body of evidence highlighting the improved sensitivity and specificity for prostate specific membrane antigen (PSMA) positron emission tomography (PET) in advanced prostate cancer imaging. We aimed to assess prostate cance...

Impact on prostate cancer clinical presentation after non-screening policies at a terti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871577
BMC Urology; Ajami T, Durruty J et. al.

Feb 9th, 2021 - In May 2012 the US Preventive Task Force issued a 'D' recommendation against routine PSA-based early detection of prostate cancer. This recommendation was implemented progressively in our health system. The aim of this study is to define its impac...

Incidental finding of ileal gastrointestinal stromal tumour during prostate cancer stag...
https://doi.org/10.1111/1754-9485.13113
Journal of Medical Imaging and Radiation Oncology; Lee DJW, Warner M et. al.

Oct 29th, 2020 - Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used in managing and staging prostate cancer, but can identify other non-prostate pathology. We present the first reported case where small bo...

A novel tool for improving the interpretation of isotope bone scans in metastatic prost...
https://doi.org/10.1259/bjr.20200775
The British Journal of Radiology; Alshehri AHD, Osman SOS et. al.

Sep 3rd, 2020 - The isotope bone scan (IBS) is the gold-standard imaging modality for detecting skeletal metastases as part of prostate cancer staging. However, its clinical utility for assessing skeletal metastatic burden is limited due to the need for subjectiv...

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcome...
https://doi.org/10.1007/s00259-020-04944-2 10.1097/PAS.0000000000000530 10.1016/S0140-6736(12)61253-7 10.1007/s00259-017-3631-6 10.1038/s41598-018-35058-3 10.1111/j.1464-410X.2010.10039.x
European Journal of Nuclear Medicine and Molecular Imaging; Roberts MJ, Morton A et. al.

Jul 22nd, 2020 - Prostate-specific membrane antigen (PSMA) positron emission tomography (PSMA-PET) improves prostate cancer staging. Intraprostatic PSMA intensity may predict clinically relevant oncological outcomes. The aim of this study was to investigate the re...

see more →

Guidelines  11 results

Early Detection of Prostate Cancer
http://www.auanet.org/guidelines/early-detection-of-prostate-cancer-(2013-reviewed-and-validity-confirmed-2015)
H. Ballentine Carter

Dec 31st, 2017 - This guideline addresses prostate cancer early detection for the purpose of reducing prostate cancer mortality with the intended user as the urologist. This document does not make a distinction between early detection and screening for prostate ca.

Treatment Recommendations for Cancer of the Prostate
https://www.esmo.org/Guidelines/Genitourinary-Cancers/Cancer-of-the-Prostate/eUpdate-Treatment-Recommendation
ESMO Gudelines Committee

Sep 27th, 2017 - Two phase III trials have compared ADT alone versus ADT plus abiraterone and prednisolone in men with metastatic, hormone-naive disease. The LATITUDE trial included men with high risk metastatic disease.

Second-Line Hormonal Therapy for Men with Chemotherapy-Naïve Castration-Resistant Prostate C...
http://ascopubs.org/doi/full/10.1200/JCO.2017.72.8030
Katherine S. Virgo

Jun 9th, 2017 - ASCO provisional clinical opinions (PCOs) offer direction to the ASCO membership after publication or presentation of potential practice-changing data. This PCO addresses second-line hormonal therapy for chemotherapy-naïve men with castration-resi.

Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate ...
https://www.asco.org/sites/new-www.asco.org/files/content-files/practice-and-guidelines/documents/2017-hcrpc-pco-slides.pdf
ASCO

Jun 9th, 2017 - This PCO addresses the use of the second-line hormonal therapy for chemotherapy-naïve men with castration-resistant prostate cancer (CRPC) who range from being asymptomatic with only biochemical evidence of CRPC to having documented metastases but.

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline
http://www.auanet.org/guidelines/clinically-localized-prostate-cancer-new-(aua/astro/suo-guideline-2017)
Martin G. Sanda

Mar 31st, 2017 - These guidelines for the management of localized prostate cancer are structured first, to provide a clinical framework stratified by cancer severity to facilitate care decisions and second, to guide the specifics of implementing the selected manag.

see more →

Clinicaltrials.gov  111 results

Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate ...
https://doi.org/10.1111/1754-9485.13162
Journal of Medical Imaging and Radiation Oncology; Papa N, Perera M et. al.

Mar 5th, 2021 - There has been a growing body of evidence highlighting the improved sensitivity and specificity for prostate specific membrane antigen (PSMA) positron emission tomography (PET) in advanced prostate cancer imaging. We aimed to assess prostate cance...

Impact on prostate cancer clinical presentation after non-screening policies at a terti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871577
BMC Urology; Ajami T, Durruty J et. al.

Feb 9th, 2021 - In May 2012 the US Preventive Task Force issued a 'D' recommendation against routine PSA-based early detection of prostate cancer. This recommendation was implemented progressively in our health system. The aim of this study is to define its impac...

New Prostate Cancer Staging System May Improve Pretreatment Prognostication
https://www.staging.medscape.com/viewarticle/940086

Nov 1st, 2020 - NEW YORK (Reuters Health) - A pretreatment, predictive staging system for nonmetastatic prostate cancer, based on data analysis rather than expert consensus, promises to improve on existing risk-stratification systems, according to an internationa...

New Prostate Cancer Staging System May Improve Pretreatment Prognostication
https://www.medscape.com/viewarticle/940086

Nov 1st, 2020 - NEW YORK (Reuters Health) - A pretreatment, predictive staging system for nonmetastatic prostate cancer, based on data analysis rather than expert consensus, promises to improve on existing risk-stratification systems, according to an internationa...

Incidental finding of ileal gastrointestinal stromal tumour during prostate cancer stag...
https://doi.org/10.1111/1754-9485.13113
Journal of Medical Imaging and Radiation Oncology; Lee DJW, Warner M et. al.

Oct 29th, 2020 - Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used in managing and staging prostate cancer, but can identify other non-prostate pathology. We present the first reported case where small bo...

see more →

News  2 results

New Prostate Cancer Staging System May Improve Pretreatment Prognostication
https://www.staging.medscape.com/viewarticle/940086

Nov 1st, 2020 - NEW YORK (Reuters Health) - A pretreatment, predictive staging system for nonmetastatic prostate cancer, based on data analysis rather than expert consensus, promises to improve on existing risk-stratification systems, according to an internationa...

New Prostate Cancer Staging System May Improve Pretreatment Prognostication
https://www.medscape.com/viewarticle/940086

Nov 1st, 2020 - NEW YORK (Reuters Health) - A pretreatment, predictive staging system for nonmetastatic prostate cancer, based on data analysis rather than expert consensus, promises to improve on existing risk-stratification systems, according to an internationa...

see more →

Patient Education  1 results see all →